Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Applied Behavior Analysis
Mitochondrial damage during myocardial ischemia.
Pinocytosis
Retinol-Binding Proteins
Tolerance and toxicity of the PARP inhibitor olaparib in older women with epithelial ovarian cancer.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Tolerance and toxicity of the PARP inhibitor olaparib in older women with epithelial ovarian cancer.
Tolerance and toxicity of the PARP inhibitor olaparib in older women with epithelial ovarian cancer. Gynecol Oncol. 2017 12; 147(3):509-513.
View in:
PubMed
subject areas
Age Factors
Aged
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Female
Humans
Neoplasm Recurrence, Local
Neoplasms, Glandular and Epithelial
Ovarian Neoplasms
Phthalazines
Piperazines
Poly(ADP-ribose) Polymerase Inhibitors
Prospective Studies
Randomized Controlled Trials as Topic
authors with profiles
Kai Ding
Lauren E Dockery